B. Riley Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History

B. Riley Wealth Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,433	Closed	-$19.2K	–	1301
2024 Q2	$19.2K	Sell	1,433 -1,462	-51%	-$43.6K	﹤0.01%	1365
2024 Q1	$210K	Sell	2,895 -1,846	-39%	-$95.6K	0.01%	1250
2023 Q4	$321K	Buy	4,741 +1,846	+64%	+$113K	0.01%	1019
2023 Q3	$210K	Buy	2,895 +1,279	+79%	+$102K	0.01%	1250
2023 Q2	$120K	Buy	1,616 +38	+2%	+$2.25K	﹤0.01%	1416
2023 Q1	$84K	Sell	1,578 -169	-10%	-$10.7K	﹤0.01%	1399
2022 Q4	$118K	Buy	+1,747	New	+$161K	﹤0.01%	1340
2021 Q4	–	Sell	-256	Closed	-$119K	–	1433
2021 Q3	$119K	Buy	+256	New	+$125K	﹤0.01%	1316

Other funds holding DNA

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Two Sigma Advisers

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return